The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Paraquat exposure as an etiological factor of Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
THE MITOCHONDRIAL ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION SYSTEM
Hatefi, Y. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.005055 · Cited by 1,680
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,376
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · cited 1×
“Comparing to other neuronal cell types, dopaminergic cells are much more sensitive to oxidative injury due to the participation of DA in harmful oxidative reactions (Fitsanakis et al., 2002; Graham, 1978).”
BackgroundThe epidemiology of Parkinson's disease
Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., & Tanner, C. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01419-8 · Cited by 967
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
Are men at greater risk for Parkinson's disease than women?
Wooten, G. F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020982 · Cited by 695
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Aging and Extrapyramidal Function
McGeer, P. L., McGeer, E. G., & Suzuki, J. S. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500130053010 · Cited by 647
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., & Richardson, R. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 639
Environmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Holland, I. B., & A. Blight, M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2993 · Cited by 578
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537
Uversky, V. N. (2003) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2003.10506918 · Cited by 500
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
Parkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 439
Seidler, A., Hellenbrand, W., Robra, B.-P., Vieregge, P., Nischan, P., Joerg, J., Oertel, W. H., Ulm, G., & Schneider, E. (1996) · Neurology · doi:10.1212/wnl.46.5.1275 · Cited by 433
Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
(1999) · PubMed · Cited by 425
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Cloning and Functional Expression of a Human Liver Organic Cation Transporter
Zhang, L., Dresser, M. J., Gray, A. T., Yost, S. C., Terashita, S., & Giacomini, K. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.913 · Cited by 417
Ara, J., Przedborski, S., Naini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J., & Ischiropoulos, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7659 · Cited by 414
Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-Tetrahydropyridine
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090511 · Cited by 406
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376
Wu, X., Kekuda, R., Huang, W., Fei, Y.-J., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32776 · Cited by 370
Marsden, C. D. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.6.672 · Cited by 365
Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 361
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 350
Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02597-2 · Cited by 350
Complex I and Parkinson's Disease
Greenamyre, J. T., Sherer, T. B., Betarbet, R., & Panov, A. V. (2001) · IUBMB Life · doi:10.1080/15216540152845939 · Cited by 337
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 332
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O'Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306
Piccini, P., Burn, D. J., Ceravolo, R., Maraganore, D., & Brooks, D. J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<577::aid-ana5>3.0.co;2-o · Cited by 304
Glutathione‐related enzymes in brain in Parkinson's disease
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360306 · Cited by 296
Parkinson's disease: A case‐control study of occupational and environmental risk factors
Hertzman, C., Wiens, M., Bowering, D., Snow, B., & Calne, D. (1990) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700170307 · Cited by 290
Excitotoxicity and nitric oxide in parkinson's disease pathogenesis
Beal, M. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440716 · Cited by 283
William Langston, J., & Ballard, P. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046333 · Cited by 281
Thiruchelvam, M., McCormack, A., Richfield, E. K., Baggs, R. B., Tank, A. W., Di Monte, D. A., & Cory‐Slechta, D. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02781.x · Cited by 280
The role of environmental toxins in the etiology of Parkinson's disease
Tanner, C. M. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90135-5 · Cited by 276
Neural mechanisms in disorders of movement
Crossman, A. R. (1989) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(89)90201-6 · Cited by 275
Parkinson's disease: A test of the multifactorial etiologic hypothesis
Semchuk, K. M., Love, E. J., & Lee, R. G. (1993) · Neurology · doi:10.1212/wnl.43.6.1173 · Cited by 275
Familial Aggregation of Parkinson's Disease in Iceland
Sveinbjörnsdóttir, S., Hicks, A. A., Jónsson, T., Pétursson, H., Guðmundsson, G., Frigge, M. L., Kong, A., Gulcher, J. R., & Stefánsson, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432404 · Cited by 275
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263
Movement disorders : neurologic principles and practice
Watts, R. L., & Koller, W. C. (1997) · McGraw-Hill, Health Professions Division eBooks · Cited by 255
Fall, P.-A., Fredrikson, M., Axelson, O., & Gran�rus, A.-K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<28::aid-mds1007>3.0.co;2-o · Cited by 244
Anatomical and chemical studies of a nigro-neostriatal projection in the cat
Moore, R. Y., Bhatnagar, R. K., & Heller, A. (1971) · Brain Research · doi:10.1016/0006-8993(71)90009-6 · Cited by 243
Environmental Factors in Parkinson’s Disease
Di Monte, D. A., Lavasani, M., & Manning-Bog, A. B. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00099-2 · Cited by 240
Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
Stein, W. D. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.545 · Cited by 239
Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype
Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., & Cory-Slechta, D. A. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00092-x · Cited by 214
A mechanism of paraquat toxicity involving nitric oxide synthase
Day, B. J., Patel, M., Calavetta, L., Chang, L.-Y., & Stamler, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12760 · Cited by 206
Uversky, V. N., Li, J., Bower, K., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00067-0 · Cited by 200
Nigral and extranigral pathology in Parkinson's disease.
Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198
Hellenbrand, W., Boeing, H., Robra, B.-P., Seidler, A., Vieregge, P., Nischan, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.644 · Cited by 195
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease
Klockgether, T., & Turski, L. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90007-6 · Cited by 186
Plantation Work and Risk of Parkinson Disease in a Population-Based Longitudinal Study
Petrovitch, H., Ross, G. W., Abbott, R. D., Sanderson, W. T., Sharp, D. S., Tanner, C. M., Masaki, K. H., Blanchette, P. L., Popper, J. S., Foley, D., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1787 · Cited by 185
The etiology of Parkinson's disease with emphasis on the MPTP story
Langston, J. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.153s · Cited by 180
Peroxynitrite and Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Ebadi, M., & Sharma, S. K. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603322110896 · Cited by 176
Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic mice
Thiruchelvam, M. J., Powers, J. M., Cory‐Slechta, D. A., & Richfield, E. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03139.x · Cited by 174
Aluminum-containing antacids as a cause of idiopathic Parkinson's disease
Altschuler, E. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0701 · Cited by 173
Movement disorders: Neurologic principles and practice
Uitti, R. J. (1997) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(97)87971-0 · Cited by 170
Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain
Morano, A. E., Jiménez‐Jiménez, F. J., Pérez-Molina, J. A., & Antolín, M. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb01655.x · Cited by 165
Calcium, magnesium and aluminum concentrations in Parkinson's disease.
YASUI, M., Kihira, T., & Ota, K. (1992) · PubMed · Cited by 163
Prevalence, incidence, and mortality of PD
Chen, R.-T., Chang, S.-S., Su, C., Chen, T. H. H., Yen, M. F., Wu, H. M., Chen, Z., & Liou, H. (2001) · Neurology · doi:10.1212/wnl.57.9.1679 · Cited by 156
The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS Disorders
Taylor, E. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241020-00001 · Cited by 153
LaVoie, M. J., & Hastings, T. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732546.x · Cited by 150
Oxygen species in paraquat toxicity: the crypto‐OH radical
Youngman, R. J., & Elstner, E. F. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80180-9 · Cited by 149
Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity
Monte, D. A. D., Sandy, M. S., Ekström, G., & Smith, M. T. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91210-6 · Cited by 145
Shimizu, K., Matsubara, K., Ohtaki, K., Fujimaru, S., Saito, O., & Shiono, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02750-1 · Cited by 142
Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease
Greenamyre, J. T. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245235 · Cited by 133
Effects of l ‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration
McCormack, A. L., & Monte, D. A. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 131
Genetics of Parkinson’s Disease
Singleton, A., & Clarimón, J. (2007) · CRC Press eBooks · doi:10.3109/9781420019223-5 · Cited by 124
Genetics of Parkinson's disease
Gasser, T. (2001) · Journal of Neurology · doi:10.1007/s004150170066 · Cited by 124
Cerebral damage in paraquat poisoning
Grant, H. C., Lantos, P. L., & Parkinson, M. C. (1980) · Histopathology · doi:10.1111/j.1365-2559.1980.tb02911.x · Cited by 119
Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin
Lindquist, N. G., Larsson, B. S., & Lydén‐Sokolowski, A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90002-x · Cited by 115
A Pure Parkinsonian Syndrome Following Acute Carbon Monoxide Intoxication
Klawans, H. L., Stein, R. W., Tanner, C. M., & Goetz, C. G. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510170044012 · Cited by 114
Tawara, T., Fukushima, T., Hojo, N., Isobe, A., Shiwaku, K., Setogawa, T., & Yamane, Y. (1996) · Archives of Toxicology · doi:10.1007/s002040050316 · Cited by 112
Genetics of Parkinson's disease.
Gasser, T. (2004) · Europe PMC (PubMed Central) · Cited by 111
Modulation of Antioxidant Defense Systems by the Environmental Pesticide Maneb in Dopaminergic Cells
Barlow, B. K., Lee, D. W., Cory‐Slechta, D. A., & Opanashuk, L. A. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.07.004 · Cited by 107
Liou, H., Chen, R.-C., Tsai, Y.-F., Chen, W., Chang, Y.-C., & Tsai, M.-C. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0054 · Cited by 105
Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides
Fitsanakis, V. A., Amarnath, V., Moore, J. T., Montine, K. S., Zhang, J., & Montine, T. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01169-3 · Cited by 100
Hansen, L. A., & Galasko, D. (1992) · PubMed · Cited by 99
Mechanism of cytotoxicity of paraquat
Fukushima, T., Yamada, K., Isobe, A., Shiwaku, K., & Yamane, Y. (1993) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80424-0 · Cited by 98
Hernandez, D. G., Ruiz, C. P., Crawley, A., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.044 · Cited by 98
Orth, M., & Tabrizi, S. J. (2003) · Movement Disorders · doi:10.1002/mds.10447 · Cited by 97
Epidemiology of Parkinson’s Disease
Khandhar, S. M., & Marks, W. J. (2007) · Disease-a-Month · doi:10.1016/j.disamonth.2007.02.001 · Cited by 94
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture
Shimizu, K., Matsubara, K., Ohtaki, K., & Shiono, H. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00163-9 · Cited by 94
P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity
Dinis‐Oliveira, R. J., Remião, F., Duarte, J. A., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.06.012 · Cited by 91
Self-citationClejan, L. A., & Cederbaum, A. I. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90412-7 · Cited by 90
Pathophysiology of synuclein aggregation in Lewy body disease
Mukaetova‐Ladinska, E. B., & McKeith, I. G. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.014 · Cited by 87
Mechanism of cytotoxicity of paraquat
Fukushima, T., Yamada, K., Hojo, N., Isobe, A., Shiwaku, K., & Yamane, Y. (1994) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80056-4 · Cited by 86
Hughes, J. T. (1988) · PubMed · Cited by 85
Limited Blood‐Brain Barrier Transport of Polyamines
Shin, W. ‐., Fong, W. F., Pang, S., & Wong, P. C. L. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb08724.x · Cited by 84
Frequency and Cause of Parkinson’s Disease
Rajput, A. H. (1992) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100041457 · Cited by 76
Barlow, B. K., Thiruchelvam, M. J., Bennice, L., Cory‐Slechta, D. A., Ballatori, N., & Richfield, E. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01773.x · Cited by 73
Paraquat: A Useful Tool for thein vivoStudy of Mechanisms of Neuronal Cell Death
Corasaniti, M. T., Strongoli, M. C., Rotiroti, D., Bagetta, G., & Nisticò, G. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01434.x · Cited by 73
Environmental risk factors for Parkinson's disease in an urban multiethnic community
Marder, K. S., Logroscino, G., Alfaro, B., Mejía, H., Halim, A., Louis, E. K. S., Cote, L. J., & Mayeux, R. P. (1998) · Neurology · doi:10.1212/wnl.50.1.279 · Cited by 63
Genetics of parkinson's disease
Gasser, T. (1998) · Annals of Neurology · doi:10.1002/ana.410440708 · Cited by 62
Perry, T. L., Yong, V. W., Wall, R. A., & Jones, K. L. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90495-7 · Cited by 58
Mechanism of cytotoxicity of paraquat
Yamada, K., & Fukushima, T. (1993) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80433-1 · Cited by 55
Widdowson, P. S., Farnworth, M. J., Simpson, M., & Lock, E. (1996) · Human & Experimental Toxicology · doi:10.1177/096032719601500308 · Cited by 50
Paraquat and Parkinson's disease
Koller, W. C. (1986) · Neurology · doi:10.1212/wnl.36.8.1147-b · Cited by 50
Paraquat-Induced Free Radical Reaction in Mouse Brain Microsomes
Yang, W., & Sun, A. Y. (1998) · Neurochemical Research · doi:10.1023/a:1022497319548 · Cited by 48
Dicker, E., & Cederbaum, A. I. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90315-v · Cited by 48
Clinical and pathological features in hydrocarbon‐induced Parkinsonism
Pezzoli, G., Strada, O., Silani, V., Zecchinelli, A., Perbellini, L., Javoy-Agid, F., Ghidoni, P., Motti, E., Masini, T., Scarlato, G., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400616 · Cited by 40
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users
Vanacore, N., Nappo, A., Gentile, M., Brustolin, A. L., Palange, S., Liberati, A. M., Rezze, S. D., Caldora, G., Gasparini, M., Benedetti, F. M. N., et al. (2002) · Neurological Sciences · doi:10.1007/s100720200098 · Cited by 35
The role of environmental agents in Parkinson's disease
Monte, D. A. D. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00020-2 · Cited by 32
The role of respiratory chain in paraquat toxicity in yeast.
Błaszczyński, M., Litwińska, J., Zaborowska, D., & Biliński, T. (1985) · PubMed · Cited by 18
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
Dinis-Oliveira, R. J., Duarte, J. A., Sánchez-Navarro, A., Remião, F., Bastos, M. L., & Carvalho, F. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440701669959 · Cited by 926
Self-citationMitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 841
Costello, S., Cockburn, M., Bronstein, J., Zhang, X., & Ritz, B. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp006 · Cited by 581
Complex I Is the Major Site of Mitochondrial Superoxide Production by Paraquat
Cochemé, H. M., & Murphy, M. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708597200 · Cited by 571
Metadata
- Authors
- Dinis-Oliveira, R. J., Remião, F., Carmo, H., Duarte, J. A., Navarro, A. S., Bastos, M. L., & Carvalho, F.
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 27
- Issue
- 6
- Pages
- 1110-1122
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2054561574
- Cited by
- 329
- References
- 127
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.